• Markets
    • icon
  • Companies
VIT · ASX

Vitura Health Limited (ASX:VIT)

AU$0.093

 -0.005 (-5.102%)
ASX:Live
26/07/2024 04:10:15 PM
Hammer Bearish HALO Ords GROWTH AUS Consensus Cheap All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

VIT Overview

VIT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About VIT

Website

Vitura Health Limited

Telephone

61.13.0079.9491

Address

Suite 8, Level 3 299 Toorak Road South Yarra, Victoria (VIC) 3141

Description

Vitura Health Ltd. engages in the sale and distribution of medicinal cannabis products and the operation of medicinal cannabis clinic businesses. It operates through the following segments: Medical, Clinics, and Consumer. The Medical segment is involved in the sale of medicinal cannabis products. The Clinics segment focuses on the operation of medicinal cannabis clinics. The Consumer segment refers to the sale of consumer non-medical products in Australia and previously in Asia. The company was founded on September 27, 2018 and is headquartered in South Yarra, Australia.

VIT Price Chart

Key Stats

Market Cap

AU$55.86M

PE

9.70

EV/EBITDA

0.0

Dividends Overview

DIV Yield

3.5%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.08 - 0.53

Trade Value (12mth)

AU$21,645.00

1 week

7.69%

1 month

6.52%

YTD

-59.17%

1 year

-80.4%

All time high

1.04

Key Fundamentals

EPS 3 yr Growth

-158.000%

EBITDA Margin

17.80%

Operating Cashflow

$10m

Free Cash Flow Return

29.10%

ROIC

41.40%

Interest Coverage

614.30

Quick Ratio

2.70

Other Data

Shares on Issue (Fully Dilluted)

569m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

VIT Announcements

Latest Announcements

Date Announcements

01 July 24

Notification of cessation of securities - VIT

×

Notification of cessation of securities - VIT

03 June 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

31 May 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

29 May 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

24 May 24

Investor Conference Call Today 3pm

×

Investor Conference Call Today 3pm

24 May 24

VIT Strategy Reset Presentation

×

VIT Strategy Reset Presentation

22 May 24

Vitura Strategy Reset

×

Vitura Strategy Reset

30 April 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

26 April 24

Update on Services Agreement with Code4 Cannabis

×

Update on Services Agreement with Code4 Cannabis

26 April 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

26 April 24

Change in substantial holding

×

Change in substantial holding

26 April 24

Final Director's Interest Notice

×

Final Director's Interest Notice

24 April 24

Notification of cessation of securities - VIT

×

Notification of cessation of securities - VIT

23 April 24

Services Agreement with Code4 Cannabis

×

Services Agreement with Code4 Cannabis

22 April 24

CEO transition

×

CEO transition

22 April 24

Pause in Trading

×

Pause in Trading

22 April 24

Trading Halt

×

Trading Halt

18 April 24

Release of shares from escrow

×

Release of shares from escrow

05 April 24

Local manufacture of MDMA

×

Local manufacture of MDMA

18 March 24

First supply of Psilocybin

×

First supply of Psilocybin

28 February 24

Change in substantial holding

×

Change in substantial holding

26 February 24

ASX Appendix 4D

×

ASX Appendix 4D

26 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

26 February 24

Investor webinar and presentation

×

Investor webinar and presentation

13 February 24

Appointment of Independent Chair

×

Appointment of Independent Chair

13 February 24

Initial Director's Interest Notice

×

Initial Director's Interest Notice

VIT Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.00 0.01 0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.00 0.01 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 108.2 257.1 99.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A 9.7 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.01 0.02 0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.00 0.03 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 118.3 355.1 12.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock 2.1 10.8 1.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A 3.5 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 80 40 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.05 0.06 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.03 0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock -90.6 264.8 45.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 402 487 572 Lock Lock Lock
Basic m Lock Lock Lock Lock 402 482 555 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 22 67 117 Lock Lock Lock
     Growth % Lock Lock Lock Lock 17,431.0 208.5 75.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 1 3 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 3 13 26 Lock Lock Lock
     Growth % Lock Lock Lock Lock 203.8 295.5 105.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 14.7 18.8 22.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 85 81 78 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 2 11 21 Lock Lock Lock
     Growth % Lock Lock Lock Lock 146.7 456.6 96.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 8.8 15.8 17.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 2 10 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 141.2 483.8 100.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 7.8 14.8 16.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 2 10 20 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 4 6 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 1 6 14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 136.0 326.7 128.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.5 9.0 11.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 1 14 10 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 2 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 -2 -6 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 1 13 9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 117.8 1,371.4 -33.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.2 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 2 16 19 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 9 43 47 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 5 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -1 -11 -18 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 5 17 12 Lock Lock Lock
Equity $m Lock Lock Lock Lock 4 26 35 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 4 31 36 Lock Lock Lock
     Growth % Lock Lock Lock Lock -71.1 581.8 17.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 16.1 14.1 29.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 35.8 23.2 39.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 36.3 46.5 59.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 31.5 30.1 41.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 23.7 67.2 29.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 68.2 24.0 614.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.7 -1.0 -0.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -34.4 -42.2 -50.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.8 2.3 3.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.0 1.9 2.7 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 27.6 58.3 52.4 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 24.9 111.0 89.3 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 10.0 21.6 15.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 6.0 17.1 15.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 6.7 4.3 4.7 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 14.5 8.8 5.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 2.5 1.6 2.5 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 2.5 1.6 2.5 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 8.7 14.5 17.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 21.4 22.7 42.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 24.9 38.3 31.4 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 16.1 14.1 29.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.2 1.6 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 35.8 23.2 39.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 20.0 59.8 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 35.8 4.6 23.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 61.1 21.4 23.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 36.6 16.9 23.5 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 97.7 38.2 47.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 62.2 20.0 25.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 35.6 18.2 22.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

3.5%

Franking Level

100%

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

VIT Shortsell

Frequently Asked Questions

The current share price of Vitura Health Limited (VIT:ASX) is AU$0.093.
The 52-week high share price for Vitura Health Limited (VIT:ASX) is AU$0.53.
The 52-week low share price for Vitura Health Limited (VIT:ASX)? is AU$0.08.
The current TTM dividend payout for Vitura Health Limited (VIT:ASX) is 3.50.
The last dividend payment of Vitura Health Limited (VIT:ASX) is AU$0.01.
Vitura Health Limited (VIT:ASX) has a franking level of 100.0%.
Vitura Health Limited (VIT:ASX) is classified in the Healthcare.
The current P/E ratio for Vitura Health Limited (VIT:ASX) is 9.70.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.